14:25 EDT U.S. files False Claims Act complaint against Elevance, Humana (HUM), Aetna
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Elevance Health price target raised to $465 from $450 at Argus
- Elevance Health’s Strong Q1 2025 Performance and Diverse Revenue Streams Justify Buy Rating
- ‘Medicaid to the Rescue,’ Says Wall St. Analyst About Elevance Health (ELV) Stock
- Elevance Health’s Growth Potential Justifies Buy Rating Amid Sector Challenges
- Buy Rating for Elevance Health: Stable Medicaid and Medicare Advantage Outlook with Potential Upside